5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine
C92H122Cl3N25O8 — CID 158616373
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine
5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine (PubChem CID 158616373) has the molecular formula C92H122Cl3N25O8 and a molecular weight of 1812.51 g/mol. Its IUPAC name is 5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine.
Molecular Properties
| Compound Name | 5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine |
|---|---|
| PubChem CID | 158616373 |
| Molecular Formula | C92H122Cl3N25O8 |
| Molecular Weight | 1812.51 g/mol |
| Exact Mass | 1809.90 |
| IUPAC Name | 5-N-[(1S,5R)-8-azabicyclo[3.2.1]octan-3-yl]-7-N-(5-methyl-1H-pyrazol-3-yl)-1,6-naphthyridine-5,7-diamine;tert-butyl (1S,5R)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl N-[(Z)-4-amino-4-iminobut-2-en-2-yl]carbamate;tert-butyl (1S,5R)-3-[(7-chloro-1,6-naphthyridin-5-yl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl (1S,5R)-3-[[7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl]amino]-8-azabicyclo[3.2.1]octane-8-carboxylate;5,7-dichloro-1,6-naphthyridine |
| SMILES | CC(C)(C)OC(=O)N1[C@@H]2CC[C@H]1CC(N)C2.CC(C)(C)OC(=O)N1[C@@H]2CC[C@H]1CC(Nc1nc(Cl)cc3ncccc13)C2.Cc1cc(Nc2cc3ncccc3c(NC3C[C@H]4CC[C@@H](C3)N4)n2)n[nH]1.Cc1cc(Nc2cc3ncccc3c(NC3C[C@H]4CC[C@@H](C3)N4C(=O)OC(C)(C)C)n2)n[nH]1.Clc1cc2ncccc2c(Cl)n1.[H]/N=C(N)/C=C(/C)NC(=O)OC(C)(C)C |
| InChI | InChI=1S/C24H31N7O2.C20H25ClN4O2.C19H23N7.C12H22N2O2.C9H17N3O2.C8H4Cl2N2/c1-14-10-21(30-29-14)27-20-13-19-18(6-5-9-25-19)22(28-20)26-15-11-16-7-8-17(12-15)31(16)23(32)33-24(2,3)4;1-20(2,3)27-19(26)25-13-6-7-14(25)10-12(9-13)23-18-15-5-4-8-22-16(15)11-17(21)24-18;1-11-7-18(26-25-11)23-17-10-16-15(3-2-6-20-16)19(24-17)22-14-8-12-4-5-13(9-14)21-12;1-12(2,3)16-11(15)14-9-4-5-10(14)7-8(13)6-9;1-6(5-7(10)11)12-8(13)14-9(2,3)4;9-7-4-6-5(8(10)12-7)2-1-3-11-6/h5-6,9-10,13,15-17H,7-8,11-12H2,1-4H3,(H3,26,27,28,29,30);4-5,8,11-14H,6-7,9-10H2,1-3H3,(H,23,24);2-3,6-7,10,12-14,21H,4-5,8-9H2,1H3,(H3,22,23,24,25,26);8-10H,4-7,13H2,1-3H3;5H,1-4H3,(H3,10,11)(H,12,13);1-4H/b;;;;6-5-;/t15?,16-,17+;12?,13-,14+;12-,13+,14?;8?,9-,10+;; |
| InChIKey | HXLBJMQBAVKNEJ-RNUKGYIESA-N |
| XLogP | 18.64 |
| TPSA | 435.50 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 128 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1812.51 |
| LogP ≤ 5 | 18.64 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 26 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158616373 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.